Recently, Uni-Bio Science Group Limited is pleased to announce a strategic cooperation with Chongqing Minji Medical Device Co., Ltd.
2024-07-10
View detailsRecord-breaking Revenue of HK$484.7M and Net Profit of HK$70.9M,Pioneering Breakthroughs in Osteoporosis, Medical Aesthetics, and Ophthalmology Markets
2024-03-28
View detailsUni-Bio Science Group Limited is pleased to announce the acceptance of its marketing application for Diquafosol Sodium eye drops by the China National Medical Products Administration (“NMPA”) on 23 January 2024, with the acceptance number “CYHS2400318“.
2024-01-23
View detailsUni-Bio Science Group Limited is excited to announce that the China National Medical Products Administration ("NMPA") has officially approved the marketing application for BOGUTAI® (teriparatide injection) on January 16, 2024. This significant milestone h
2024-01-22
View detailsUni-Bio Science 2023 Interim Results,Achieved Record High Profit of HK$39.4M,Driven by Scale-Up Operations and Remarkable Growth in Marketed Drugs,Expanding Multiple Channels and Diverse Commercialization for New Products
2023-08-29
View details